Global InformationVibroacoustic therapy information
Vibroacoustic therapy (VAT) is a type of sound therapy that involves passing low frequency sine wave vibrations into the body via a device with embedded speakers.[1][2] This therapy was developed in Norway by Olav Skille in the 1980s.[3] The Food and Drug Administration determined that vibroacoustic devices, such as the Next Wave® PhysioAcoustic therapeutic vibrator, are "substantially equivalent" to other therapeutic vibrators, which are "intended for various uses, such as relaxing muscles and relieving minor aches and pains";[4] thus, vibroacoustic devices (therapeutic vibrators) are "exempt from clinical investigations, Good Guidance Practices (GGPs), and premarket notification and approval procedures."[5]
- ^ Kantor, Jiří; Kantorová, Lucia; Marečková, Jana; Peng, Danping; Vilímek, Zdeněk (October 2019). "Potential of Vibroacoustic Therapy in Persons with Cerebral Palsy: An Advanced Narrative Review". International Journal of Environmental Research and Public Health. 16 (20): 3940. doi:10.3390/ijerph16203940. PMC 6843730. PMID 31623221.
- ^ Kvam, Marit Hoem (1997-06-01). "The Effect of Vibroacoustic Therapy". Physiotherapy. 83 (6): 290–295. doi:10.1016/S0031-9406(05)66176-7. Retrieved 2020-10-17.
- ^ "What is Vibroacoustic Therapy". Skille-Lehikoinen Centre for Vibroacoustic Therapy and Research. Retrieved 15 October 2020.
- ^ "Sec. 890.5975 Therapeutic vibrator". U.S. Food and Drug Administration. Retrieved 10 September 2022.
- ^ "NEXT WAVE PHYSIOACOUSTIC MATTRESS". U.S. Department of Health & Human Services. Retrieved 10 September 2022.